Deal with the United States: This drug will be tested against the coronary

The Pharma Novatimes company has reached an agreement with the US to continue with a test of the malaria drug hydroxyclelorine vs Covid-19 in 440 patients hospitalised, Swiss pharmacist says, Bbc, broadcasts news.net.

The medicine has been used to treat malaria for decades and has been promoted by US President Donald Trump after some anecdotal evidence suggested it could help against the coronary.

But there is no scientific evidence that really helps.

“We understand the importance of answering the scientific question if hydrocyclorina will be useful to patients with the Cardi-19,” said the company.

Laboroughs across the globe are rushing to develop a cure or a vaccine against the new coronary.